DOLUTEGRAVIR
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | DOLUTEGRAVIR |
| DrugBank ID | DB08930 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 20 |
| DL Predictions (≥0.7) | 46 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| chronic hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| cytomegalovirus infection | TxGNN Knowledge Graph | L5 |
| unclassified acute myeloid leukemia | TxGNN Knowledge Graph | L5 |
| acute myeloid leukemia with cebpa somatic mutations | TxGNN Knowledge Graph | L5 |
| acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | TxGNN Knowledge Graph | L5 |
| acute myeloid leukemia with t(9;11)(p22;q23) | TxGNN Knowledge Graph | L5 |
| acute myeloid leukemia with t(8;21)(q22;q22) translocation | TxGNN Knowledge Graph | L5 |
| acute myeloid leukemia with minimal differentiation | TxGNN Knowledge Graph | L5 |
| epithelioid sarcoma | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11